Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20233218

Company黑龙江博宇制药有限公司

Registration Date

February 28, 2023

Drug Information

Generic Name

盐酸莫西沙星氯化钠注射液

Dosage Form

注射剂

Strength

250ml：盐酸莫西沙星（按C₂₁H₂₄FN₃O₄计）0.4g与氯化钠2.0g

Drug Type

化学药品

Registration Date

February 28, 2023

Company Information

Applicant Company

Company Name黑龙江博宇制药有限公司

Company Address

黑龙江省庆安县东城区

Manufacturing Company

Company Name湖南科伦制药有限公司

Company Address

湖南省岳阳县生态工业园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸莫西沙星氯化钠注射液 - NMPA 批准文号 | MedPath